The GenomicsDB is currently experiencing server issues. Searches and related features may not be available during this time. We apologize for the inconvenience.

Region: chr19:45309039-45512650

203611 bp

Genomic Context

The genome browser snapshot is fully interactive. Mouse over track elements for more information. Click and drag to move tracks. Click and drag on top positional guide to zoom to a sub-region.

To add tracks, use the provided link to switch to the full genome browser view.

Variant Effect Impact (snpEff)

  • High
  • Moderate
  • Low
  • Modifier
  • Not Reported

Functional Genomics

Functional Genomics annotations (e.g., FANTOM5 expressed enhancers, ENCODE ChIP-Seq peaks) within the span chr19:45309039-45512650

To view functional genomics annotations on the genome browser, first select tracks in the table below and then use the provided button to load the tracks on the browser.

Hits Track Platform Cell Type Tissue Antibody Target Functional Genomics
56
DNase-seq on human Medullo
DNase-Seq medulloblastoma (D721) N/A N/A DNAse hypersensitive region
37
DNase-seq on human Gliobla
DNase-Seq glioblastoma (H54) N/A N/A DNAse hypersensitive region
32
DNase-seq on human BE2-C
DNase-Seq neuroblastoma N/A N/A DNAse hypersensitive region
28
DNase-seq on human HA-h
DNase-Seq astrocyte hippocampus N/A DNAse hypersensitive region
26
DNase-seq on human HBMEC
DNase-Seq brain microvascular endothelial cell (ScienCell 1000) N/A N/A DNAse hypersensitive region
26
H3K4me1 HM ChIP-seq on human NH-A
ChIP-seq astrocyte N/A H3K4me1 histone modification site
26
DNase-seq on human NH-A
DNase-Seq astrocyte N/A N/A DNAse hypersensitive region
21
DNase-seq on human SK-N-SH_RA
DNase-Seq neuroblastoma N/A N/A DNAse hypersensitive region
21
DNase-seq on human HA-sp
DNase-Seq astrocyte spinal cord N/A DNAse hypersensitive region
20
H4K20me1 HM ChIP-seq on human NH-A
ChIP-seq astrocyte N/A H4K20me1 histone modification site
15
H3K4me2 HM ChIP-seq on human NH-A
ChIP-seq astrocyte N/A H3K4me2 histone modification site
15
DNase-seq on human SK-N-MC
DNase-Seq neuroblastoma N/A N/A DNAse hypersensitive region
13
H3K36me3 HM ChIP-seq on human NH-A
ChIP-seq astrocyte N/A H3K36me3 histone modification site
12
H3K9ac HM ChIP-seq on human NH-A
ChIP-seq astrocyte N/A H3K9ac histone modification site
11
H3K4me3 HM ChIP-seq on human NH-A
ChIP-seq astrocyte N/A H3K4me3 histone modification site
11
CTCF TFBS ChIP-seq on human HBMEC
ChIP-seq brain microvascular endothelial cell N/A CTCF transcription factor binding site
10
CTCF TFBS ChIP-seq on human BE2-C
ChIP-seq neuroblastoma N/A CTCF transcription factor binding site
9
H3K27ac HM ChIP-seq on human NH-A
ChIP-seq astrocyte N/A H3K27ac histone modification site
9
H3K27me3 HM ChIP-seq on human NH-A
ChIP-seq astrocyte N/A H3K27me3 histone modification site
9
CTCF TFBS ChIP-seq on human Gliobla
ChIP-seq glioblastoma cell N/A CTCF transcription factor binding site
8
RAD21 TFBS ChIP-seq on human SK-N-SH_RA
ChIP-seq neuroblastoma N/A RAD21 transcription factor binding site
8
CTCF TFBS ChIP-seq on human HA-sp
ChIP-seq astrocyte spinal cord CTCF transcription factor binding site
8
CTCF TFBS ChIP-seq on human SK-N-SH_RA
ChIP-seq neuroblastoma N/A CTCF transcription factor binding site
8
CTCF TFBS ChIP-seq on human SK-N-SH_RA
ChIP-seq neuroblastoma N/A CTCF transcription factor binding site
8
POLR2A TFBS ChIP-seq on human SK-N-SH
ChIP-seq neuroblastoma N/A POLR2, POLR2A transcription factor binding site
8
FOXP2 TFBS ChIP-seq on human PFSK-1
ChIP-seq neuroectodermal tumor (PFSK-1) brain FOXP2 transcription factor binding site
7
H3K79me2 HM ChIP-seq on human NH-A
ChIP-seq astrocyte N/A H3K79me2 histone modification site
7
CTCF TFBS ChIP-seq on human NH-A
ChIP-seq astrocyte N/A CTCF transcription factor binding site
7
POLR2A TFBS ChIP-seq on human SK-N-MC
ChIP-seq neuroblastoma N/A POLR2A, POLR2 transcription factor binding site
7
TAF1 TFBS ChIP-seq on human SK-N-SH
ChIP-seq neuroblastoma N/A TAF1 transcription factor binding site
7
POLR2A TFBS ChIP-seq on human U87
ChIP-seq glioblastoma cell N/A POLR2, POLR2A transcription factor binding site
5
POLR2A TFBS ChIP-seq on human Gliobla
ChIP-seq glioblastoma cell N/A POLR2, POLR2A transcription factor binding site
4
REST TFBS ChIP-seq on human U87
ChIP-seq glioblastoma cell N/A REST transcription factor binding site
4
USF1 TFBS ChIP-seq on human SK-N-SH_RA
ChIP-seq neuroblastoma N/A USF, USF1 transcription factor binding site
4
SIN3A TFBS ChIP-seq on human SK-N-SH
ChIP-seq neuroblastoma N/A SIN3A transcription factor binding site
3
YY1 TFBS ChIP-seq on human SK-N-SH_RA
ChIP-seq neuroblastoma N/A YY1 transcription factor binding site
3
REST TFBS ChIP-seq on human PFSK-1
ChIP-seq neuroectodermal tumor (PFSK-1) brain REST transcription factor binding site
2
Expressed enhancers in astrocytes
RNA-Seq (CAGE cluster) astrocyte (ScienCell/3H) N/A N/A expressed enhancer
2
EP300 TFBS ChIP-seq on human SK-N-SH_RA
ChIP-seq neuroblastoma N/A P300, EP300 transcription factor binding site
2
GATA2 TFBS ChIP-seq on human SH-SY5Y
ChIP-seq neuroblastoma N/A GATA2 transcription factor binding site
2
REST TFBS ChIP-seq on human SK-N-SH
ChIP-seq neuroblastoma N/A REST transcription factor binding site
2
Expressed enhancers in brain tissue
RNA-Seq (CAGE cluster) N/A brain (pool, Ambion) N/A expressed enhancer
2
REST TFBS ChIP-seq on human SK-N-SH
ChIP-seq neuroblastoma N/A REST transcription factor binding site
1
TAF1 TFBS ChIP-seq on human PFSK-1
ChIP-seq neuroectodermal tumor (PFSK-1) brain TAF1 transcription factor binding site
1
Specifically expressed enhancers in brain tissue
RNA-Seq (CAGE cluster) N/A brain (pool, Ambion) N/A expressed enhancer
1
Expressed enhancers in neurons
RNA-Seq (CAGE cluster) neuron (ScienCell/3H) N/A N/A expressed enhancer
1
Specifically expressed enhancers in astrocytes
RNA-Seq (CAGE cluster) astrocyte (ScienCell/3H) N/A N/A expressed enhancer
1
FOXP2 TFBS ChIP-seq on human SK-N-MC
ChIP-seq neuroblastoma N/A FOXP2 transcription factor binding site
1
SIN3A TFBS ChIP-seq on human PFSK-1
ChIP-seq neuroectodermal tumor (PFSK-1) brain SIN3A transcription factor binding site

Co-Located Genes

Genes contained within or overlapping the span chr19:45309039-45512650.

Gene Description Location Gene Type
BCAM basal cell adhesion molecule (Lutheran blood group) chr19:45312316-45324678 protein-coding
PVRL2 poliovirus receptor-related 2 (herpesvirus entry mediator B) chr19:45349393-45392485 protein-coding
TOMM40 translocase of outer mitochondrial membrane 40 homolog (yeast) chr19:45394477-45406946 protein-coding
APOE apolipoprotein E chr19:45409039-45412650 protein-coding
APOC1 apolipoprotein C-I chr19:45417577-45422606 protein-coding
APOC4 apolipoprotein C-IV chr19:45445495-45448753 protein-coding
APOC2 apolipoprotein C-II chr19:45449239-45452822 protein-coding
RELB v-rel avian reticuloendotheliosis viral oncogene homolog B chr19:45504707-45541456 protein-coding
CLPTM1 cleft lip and palate associated transmembrane protein 1 chr19:45457842-45496604 protein-coding
APOC4-APOC2 APOC4-APOC2 readthrough (NMD candidate) chr19:45445495-45452822 ncRNA
APOC1P1 apolipoprotein C-I pseudogene 1 chr19:45430060-45434643 pseudo

Co-Located SNPs

SNPs contained within the span chr19:45309039-45512650.

9405 SNPs are contained within with this region.

Of these, the following SNPs were found to have genome-wide significance in a NIAGADS dataset or the NHGRI GWAS Catalog

NIAGADS: Alzheimer's Disease

SNPs found to be significant with a p-value < 5 x 10-8 in a NIAGADs AD GWAS summary statistics dataset.

For exome array studies, a cutoff of p-value < 1 x 10-3 was used.

See methods for more information.

Select rows in the table below and then use the provided button to add selected variants to your basket.

Variant Mapped SNP p-Value Position Accession Resource
N/A
0 chr19:45422946 NG00027
ADGC 2011: Stages 1 and 2
summary statistics for ADGC (2011): stages 1 and 2, unadjusted
N/A
1e-575 chr19:45392254 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-536 chr19:45411941 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-523 chr19:45410002 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-522 chr19:45415713 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-520 chr19:45415935 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-486 chr19:45396665 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-482 chr19:45422160 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-475 chr19:45394969 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-469 chr19:45395714 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-466 chr19:45395909 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-464 chr19:45395619 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-464 chr19:45396144 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-462 chr19:45394336 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-454 chr19:45422846 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-442 chr19:45390333 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-440 chr19:45388130 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-434 chr19:45388500 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-434 chr19:45396219 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-434 chr19:45387459 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-432 chr19:45387596 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-427 chr19:45428234 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-421 chr19:45421254 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-405 chr19:45427125 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-396 chr19:45422946 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-390 chr19:45418790 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-373 chr19:45416178 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-354 chr19:45395844 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-342 chr19:45406673 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1e-326 chr19:45413576 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.10e-266 chr19:45422946 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
N/A
2.19e-206 chr19:45392254 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
N/A
6.17e-184 chr19:45395619 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
N/A
8.13e-178 chr19:45396219 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
N/A
2.24e-167 chr19:45351516 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.70e-134 chr19:45418486 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.12e-128 chr19:45406673 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
N/A
1.70e-128 chr19:45403858 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.29e-127 chr19:45404431 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.00e-126 chr19:45404972 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.74e-126 chr19:45405062 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
3.24e-125 chr19:45407788 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
6.17e-125 chr19:45403412 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
3.72e-121 chr19:45422946 NG00027
ADGC 2011: Stage 2
summary statistics for ADGC (2011): stage 2, unadjusted
N/A
3.55e-115 chr19:45402477 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.04e-114 chr19:45401666 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
4.79e-114 chr19:45398817 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
3.24e-112 chr19:45405521 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
8.91e-109 chr19:45421100 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.51e-108 chr19:45365447 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
5.13e-104 chr19:45410444 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.20e-101 chr19:45395266 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
3.80e-101 chr19:45425460 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
5.37e-97 chr19:45395330 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45392254
3.31e-96 chr19:45392254 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
3.31e-96 chr19:45382034 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45396665
1.12e-93 chr19:45396665 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
chr19:45394969
3.55e-93 chr19:45394969 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
6.92e-89 chr19:45416291 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45411941
8.13e-89 chr19:45411941 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
9.77e-89 chr19:45357291 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.26e-88 chr19:45428459 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
4.27e-87 chr19:45357377 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.35e-86 chr19:45357003 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.82e-85 chr19:45359586 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.82e-85 chr19:45385759 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.88e-85 chr19:45356464 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
3.89e-85 chr19:45423636 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45390333
3.39e-84 chr19:45390333 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
chr19:45422160
5.01e-84 chr19:45422160 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
1.07e-83 chr19:45427353 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.05e-82 chr19:45416478 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.17e-82 chr19:45421744 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
3.47e-82 chr19:45355721 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
4.37e-82 chr19:45425175 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45422846
5.01e-82 chr19:45422846 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
chr19:45395714
4.57e-81 chr19:45395714 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
7.76e-81 chr19:45359706 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.07e-80 chr19:45398716 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
3.55e-79 chr19:45414451 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45388500
8.71e-79 chr19:45388500 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
2.09e-76 chr19:45396973 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.82e-76 chr19:45398264 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.82e-76 chr19:45397512 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45410002
2.45e-75 chr19:45410002 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
chr19:45416178
1.51e-74 chr19:45416178 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
5.75e-74 chr19:45382034 NG00027
ADGC 2011: Stages 1 and 2
summary statistics for ADGC (2011): stages 1 and 2, unadjusted
N/A
4.37e-73 chr19:45408836 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45422946
4.47e-73 chr19:45422946 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
chr19:45415713
1.15e-72 chr19:45415713 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
3.89e-72 chr19:45348522 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45395909
9.55e-71 chr19:45395909 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
chr19:45394336
4.27e-70 chr19:45394336 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
chr19:45396219
1.12e-69 chr19:45396219 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
3.02e-69 chr19:45399344 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45427125
3.47e-69 chr19:45427125 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
3.80e-69 chr19:45398785 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
4.68e-69 chr19:45324138 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
4.68e-69 chr19:45397952 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
5.50e-69 chr19:45397307 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45428234
6.76e-69 chr19:45428234 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
6.31e-68 chr19:45418961 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.20e-67 chr19:45327423 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.86e-67 chr19:45400725 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.04e-67 chr19:45399896 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.29e-67 chr19:45409167 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45395619
2.82e-67 chr19:45395619 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
2.88e-67 chr19:45357291 NG00027
ADGC 2011: Stages 1 and 2
summary statistics for ADGC (2011): stages 1 and 2, unadjusted
N/A
3.31e-67 chr19:45327309 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45421254
3.72e-67 chr19:45421254 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
4.79e-67 chr19:45403216 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
4.90e-67 chr19:45384405 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
5.50e-67 chr19:45404857 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.20e-66 chr19:45396899 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.45e-65 chr19:45337504 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.82e-65 chr19:45336443 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.00e-65 chr19:45412955 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
4.07e-65 chr19:45345623 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
4.17e-65 chr19:45421877 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
4.37e-65 chr19:45336035 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.38e-64 chr19:45326217 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.63e-64 chr19:45328367 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
9.33e-64 chr19:45329344 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45415935
1.05e-63 chr19:45415935 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
2.24e-63 chr19:45337249 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.63e-63 chr19:45341904 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.63e-63 chr19:45392254 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
1.10e-62 chr19:45342007 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45413576
1.62e-62 chr19:45413576 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
2.75e-62 chr19:45338523 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.82e-62 chr19:45342161 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
4.57e-62 chr19:45429543 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45396144
5.13e-62 chr19:45396144 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
7.76e-61 chr19:45341540 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.20e-60 chr19:45326664 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45387459
1.62e-60 chr19:45387459 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
6.17e-60 chr19:45329214 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
4.79e-59 chr19:45342114 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45406673
6.31e-59 chr19:45406673 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
1.74e-58 chr19:45357939 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
4.79e-58 chr19:45398633 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.19e-57 chr19:45396665 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
2.04e-56 chr19:45394969 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
chr19:45418790
3.09e-56 chr19:45418790 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
3.98e-56 chr19:45396219 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
4.27e-56 chr19:45395714 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
chr19:45388130
7.24e-56 chr19:45388130 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
3.55e-55 chr19:45422846 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
1.35e-54 chr19:45395266 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
N/A
5.37e-54 chr19:45411941 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
chr19:45387596
2.04e-53 chr19:45387596 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
4.68e-53 chr19:45390333 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
5.37e-53 chr19:45328379 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
5.50e-53 chr19:45328380 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.66e-52 chr19:45401868 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
3.98e-52 chr19:45382966 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
5.50e-52 chr19:45384116 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
9.33e-52 chr19:45388500 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
2.24e-50 chr19:45404691 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.45e-50 chr19:45382034 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
chr19:45394336
8.91e-50 chr19:45394336 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
3.39e-49 chr19:45396144 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
4.57e-49 chr19:45395619 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
1.15e-48 chr19:45421254 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
chr19:45395844
5.50e-48 chr19:45395844 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
2.69e-47 chr19:45337385 NG00027
ADGC 2011: Stages 1 and 2
summary statistics for ADGC (2011): stages 1 and 2, unadjusted
N/A
3.89e-47 chr19:45336035 NG00027
ADGC 2011: Stages 1 and 2
summary statistics for ADGC (2011): stages 1 and 2, unadjusted
N/A
5.01e-47 chr19:45357291 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
chr19:45411941
5.50e-47 chr19:45411941 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
8.32e-47 chr19:45383061 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.20e-46 chr19:45415935 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
1.62e-46 chr19:45415713 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
2.04e-46 chr19:45410002 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
chr19:45428234
2.14e-46 chr19:45428234 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
5.37e-46 chr19:45406673 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
7.59e-46 chr19:45388130 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
1.26e-45 chr19:45358353 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.74e-45 chr19:45382717 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
5.13e-45 chr19:45401666 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
N/A
5.62e-45 chr19:45414451 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
N/A
1.41e-44 chr19:45354296 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
3.02e-44 chr19:45408836 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
N/A
8.71e-44 chr19:45329214 NG00027
ADGC 2011: Stages 1 and 2
summary statistics for ADGC (2011): stages 1 and 2, unadjusted
N/A
1.26e-43 chr19:45387596 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
1.51e-41 chr19:45418790 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
2.34e-40 chr19:45421204 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.95e-40 chr19:45380970 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
3.39e-40 chr19:45421650 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.14e-39 chr19:45416178 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
2.24e-39 chr19:45363820 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
3.72e-36 chr19:45393516 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
5.37e-36 chr19:45341948 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.20e-34 chr19:45394211 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.45e-33 chr19:45382675 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.58e-33 chr19:45337385 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
N/A
1.82e-33 chr19:45336035 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
N/A
4.27e-33 chr19:45395844 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
5.50e-33 chr19:45352487 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45413576
2.40e-32 chr19:45413576 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
2.45e-32 chr19:45385759 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
N/A
3.09e-32 chr19:45422946 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
4.68e-32 chr19:45349402 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.29e-31 chr19:45347911 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
9.33e-31 chr19:45325738 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.29e-30 chr19:45338220 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45395266
1.38e-30 chr19:45395266 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
1.55e-30 chr19:45337863 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.74e-30 chr19:45340138 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.86e-30 chr19:45413366 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.34e-30 chr19:45338493 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.88e-30 chr19:45337737 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
4.17e-30 chr19:45329214 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
chr19:45425460
6.03e-30 chr19:45425460 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
1.26e-29 chr19:45342241 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
4.47e-29 chr19:45327459 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.05e-28 chr19:45361646 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.48e-28 chr19:45365604 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.86e-28 chr19:45383061 NG00027
ADGC 2011: Stages 1 and 2
summary statistics for ADGC (2011): stages 1 and 2, unadjusted
N/A
4.57e-28 chr19:45341759 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
7.41e-28 chr19:45404691 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
N/A
9.12e-28 chr19:45379746 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45406673
2.95e-27 chr19:45406673 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
5.13e-27 chr19:45356141 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.15e-26 chr19:45382034 NG00027
ADGC 2011: Stage 2
summary statistics for ADGC (2011): stage 2, unadjusted
chr19:45414451
5.01e-26 chr19:45414451 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
chr19:45416478
7.08e-26 chr19:45416478 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
1.62e-24 chr19:45383037 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45418486
2.51e-24 chr19:45418486 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
3.55e-24 chr19:45322744 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
6.92e-24 chr19:45383037 NG00027
ADGC 2011: Stages 1 and 2
summary statistics for ADGC (2011): stages 1 and 2, unadjusted
N/A
7.08e-24 chr19:45382984 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45405062
1.32e-23 chr19:45405062 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
1.48e-23 chr19:45370554 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.04e-23 chr19:45357291 NG00027
ADGC 2011: Stage 2
summary statistics for ADGC (2011): stage 2, unadjusted
N/A
5.89e-23 chr19:45365641 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
9.77e-23 chr19:45426792 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.23e-22 chr19:45412079 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45404431
2.09e-22 chr19:45404431 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
chr19:45403412
2.34e-22 chr19:45403412 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
chr19:45403858
2.57e-22 chr19:45403858 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
2.75e-22 chr19:45364782 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45404972
2.75e-22 chr19:45404972 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
chr19:45409167
3.63e-22 chr19:45409167 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
chr19:45407720
4.68e-22 chr19:45407720 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
2.00e-21 chr19:45366275 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45421100
2.14e-21 chr19:45421100 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
2.82e-21 chr19:45463386 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
8.13e-21 chr19:45383061 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
chr19:45429099
8.91e-21 chr19:45429099 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
chr19:45421877
1.26e-20 chr19:45421877 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
2.69e-20 chr19:45365476 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
3.31e-20 chr19:45395266 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
chr19:45423934
3.63e-20 chr19:45423934 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
chr19:45426813
3.63e-20 chr19:45426813 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
chr19:45400775
4.90e-20 chr19:45400775 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
chr19:45407437
8.13e-20 chr19:45407437 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
chr19:45405521
8.32e-20 chr19:45405521 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
chr19:45407118
8.71e-20 chr19:45407118 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
9.55e-20 chr19:45370854 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.02e-19 chr19:45370649 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.29e-19 chr19:45370673 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45403858
1.41e-19 chr19:45403858 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
chr19:45403119
1.62e-19 chr19:45403119 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
chr19:45402470
1.91e-19 chr19:45402470 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
chr19:45418961
2.00e-19 chr19:45418961 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
chr19:45401666
2.04e-19 chr19:45401666 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
chr19:45398817
2.09e-19 chr19:45398817 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
2.34e-19 chr19:45365072 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45402477
2.40e-19 chr19:45402477 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
chr19:45396673
2.63e-19 chr19:45396673 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
3.39e-19 chr19:45338493 NG00027
ADGC 2011: Stages 1 and 2
summary statistics for ADGC (2011): stages 1 and 2, unadjusted
chr19:45404579
3.55e-19 chr19:45404579 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
chr19:45404431
3.80e-19 chr19:45404431 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
3.98e-19 chr19:45363700 NG00027
ADGC 2011: Stages 1 and 2
summary statistics for ADGC (2011): stages 1 and 2, unadjusted
N/A
4.90e-19 chr19:45327459 NG00027
ADGC 2011: Stages 1 and 2
summary statistics for ADGC (2011): stages 1 and 2, unadjusted
chr19:45351516
5.50e-19 chr19:45351516 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
chr19:45403412
5.89e-19 chr19:45403412 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
6.03e-19 chr19:45352804 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
7.41e-19 chr19:45352419 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45404972
7.76e-19 chr19:45404972 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
8.13e-19 chr19:45362809 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.00e-18 chr19:45353261 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.00e-18 chr19:45366779 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.10e-18 chr19:45366656 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.26e-18 chr19:45366830 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.26e-18 chr19:45368082 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45404691
1.58e-18 chr19:45404691 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
2.09e-18 chr19:45504527 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.09e-18 chr19:45363254 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.09e-18 chr19:45366345 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.19e-18 chr19:45351746 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45424624
2.34e-18 chr19:45424624 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
2.40e-18 chr19:45505803 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.40e-18 chr19:45366178 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.57e-18 chr19:45442519 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.57e-18 chr19:45365817 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.57e-18 chr19:45365961 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.57e-18 chr19:45364815 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.95e-18 chr19:45363299 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
3.31e-18 chr19:45507542 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
4.37e-18 chr19:45351937 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
5.13e-18 chr19:45371594 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
5.13e-18 chr19:45362269 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
5.75e-18 chr19:45346768 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
5.89e-18 chr19:45364623 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
5.89e-18 chr19:45361825 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45425175
6.03e-18 chr19:45425175 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
chr19:45405062
6.03e-18 chr19:45405062 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
6.61e-18 chr19:45361632 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
8.32e-18 chr19:45362667 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
8.91e-18 chr19:45366603 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
9.55e-18 chr19:45507671 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
9.55e-18 chr19:45343579 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.15e-17 chr19:45389174 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45402368
1.23e-17 chr19:45402368 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
1.35e-17 chr19:45361224 NG00027
ADGC 2011: Stages 1 and 2
summary statistics for ADGC (2011): stages 1 and 2, unadjusted
N/A
1.45e-17 chr19:45455921 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45410444
1.95e-17 chr19:45410444 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
2.04e-17 chr19:45367502 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.04e-17 chr19:45358235 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.51e-17 chr19:45363392 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
3.02e-17 chr19:45348253 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45385759
3.24e-17 chr19:45385759 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
5.89e-17 chr19:45421100 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
chr19:45384405
6.76e-17 chr19:45384405 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
7.59e-17 chr19:45444566 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
9.55e-17 chr19:45386634 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45407788
1.32e-16 chr19:45407788 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
chr19:45408475
1.58e-16 chr19:45408475 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
1.62e-16 chr19:45403412 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
2.04e-16 chr19:45313715 NG00027
ADGC 2011: Stages 1 and 2
summary statistics for ADGC (2011): stages 1 and 2, unadjusted
N/A
2.24e-16 chr19:45403924 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.40e-16 chr19:45403858 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
2.51e-16 chr19:45329214 NG00027
ADGC 2011: Stage 2
summary statistics for ADGC (2011): stage 2, unadjusted
N/A
2.82e-16 chr19:45349963 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.88e-16 chr19:45337385 NG00027
ADGC 2011: Stage 2
summary statistics for ADGC (2011): stage 2, unadjusted
N/A
2.95e-16 chr19:45442528 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
3.02e-16 chr19:45336035 NG00027
ADGC 2011: Stage 2
summary statistics for ADGC (2011): stage 2, unadjusted
chr19:45423636
3.24e-16 chr19:45423636 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
3.24e-16 chr19:45363700 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
3.39e-16 chr19:45443504 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
3.47e-16 chr19:45370838 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
3.55e-16 chr19:45402718 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45407788
4.17e-16 chr19:45407788 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
4.68e-16 chr19:45440529 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
4.79e-16 chr19:45425460 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
5.01e-16 chr19:45455905 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
5.89e-16 chr19:45404431 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
6.31e-16 chr19:45363700 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
chr19:45428459
7.08e-16 chr19:45428459 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
7.24e-16 chr19:45421744 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
7.41e-16 chr19:45442962 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
8.13e-16 chr19:45443088 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
9.77e-16 chr19:45442349 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.00e-15 chr19:45370838 NG00027
ADGC 2011: Stages 1 and 2
summary statistics for ADGC (2011): stages 1 and 2, unadjusted
chr19:45398206
1.15e-15 chr19:45398206 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
1.35e-15 chr19:45404972 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
1.38e-15 chr19:45441907 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45382034
1.70e-15 chr19:45382034 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
1.78e-15 chr19:45444742 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45390333
1.82e-15 chr19:45390333 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
1.82e-15 chr19:45405062 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
chr19:45416291
2.09e-15 chr19:45416291 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
chr19:45398633
2.19e-15 chr19:45398633 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
2.29e-15 chr19:45455901 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.82e-15 chr19:45404691 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
3.02e-15 chr19:45361224 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45422160
3.39e-15 chr19:45422160 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
4.57e-15 chr19:45440761 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
5.13e-15 chr19:45383139 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
5.37e-15 chr19:45383115 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
6.03e-15 chr19:45383079 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
6.76e-15 chr19:45369203 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45365447
6.92e-15 chr19:45365447 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
8.13e-15 chr19:45401666 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
8.51e-15 chr19:45351937 NG00027
ADGC 2011: Stages 1 and 2
summary statistics for ADGC (2011): stages 1 and 2, unadjusted
N/A
9.77e-15 chr19:45344722 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.07e-14 chr19:45351746 NG00027
ADGC 2011: Stages 1 and 2
summary statistics for ADGC (2011): stages 1 and 2, unadjusted
chr19:45423636
1.10e-14 chr19:45423636 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
chr19:45395714
1.12e-14 chr19:45395714 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
chr19:45396219
1.23e-14 chr19:45396219 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
1.62e-14 chr19:45347636 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.78e-14 chr19:45383037 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
N/A
1.86e-14 chr19:45361224 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
N/A
2.14e-14 chr19:45366410 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45427353
2.40e-14 chr19:45427353 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
2.51e-14 chr19:45388241 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.63e-14 chr19:45500712 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.88e-14 chr19:45402477 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
3.39e-14 chr19:45362667 NG00027
ADGC 2011: Stages 1 and 2
summary statistics for ADGC (2011): stages 1 and 2, unadjusted
N/A
3.55e-14 chr19:45338493 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
N/A
3.63e-14 chr19:45416478 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
4.27e-14 chr19:45398817 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
4.57e-14 chr19:45327459 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
N/A
5.37e-14 chr19:45345773 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
5.50e-14 chr19:45370854 NG00027
ADGC 2011: Stages 1 and 2
summary statistics for ADGC (2011): stages 1 and 2, unadjusted
chr19:45388500
5.75e-14 chr19:45388500 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
6.31e-14 chr19:45428459 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
6.46e-14 chr19:45366779 NG00027
ADGC 2011: Stages 1 and 2
summary statistics for ADGC (2011): stages 1 and 2, unadjusted
N/A
7.24e-14 chr19:45345283 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
8.91e-14 chr19:45414451 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
chr19:45421744
1.12e-13 chr19:45421744 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
1.17e-13 chr19:45365248 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.35e-13 chr19:45380961 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.48e-13 chr19:45345787 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.91e-13 chr19:45363791 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45395330
1.95e-13 chr19:45395330 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
2.19e-13 chr19:45358026 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.29e-13 chr19:45490192 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.82e-13 chr19:45324138 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
chr19:45386855
2.82e-13 chr19:45386855 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
3.39e-13 chr19:45377842 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45416741
3.39e-13 chr19:45416741 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
4.57e-13 chr19:45407788 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
4.79e-13 chr19:45379516 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
7.41e-13 chr19:45370838 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
N/A
8.13e-13 chr19:45357377 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
8.91e-13 chr19:45377334 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
9.77e-13 chr19:45359586 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
1.07e-12 chr19:45359706 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
1.15e-12 chr19:45493061 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.48e-12 chr19:45495682 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.62e-12 chr19:45483438 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.66e-12 chr19:45416291 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
1.82e-12 chr19:45477381 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.95e-12 chr19:45378144 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.34e-12 chr19:45490570 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.45e-12 chr19:45382675 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
2.75e-12 chr19:45496776 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
2.82e-12 chr19:45499388 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
3.02e-12 chr19:45449199 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45410444
3.09e-12 chr19:45410444 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
chr19:45421100
3.16e-12 chr19:45421100 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
3.63e-12 chr19:45343664 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
4.37e-12 chr19:45379060 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45420343
4.57e-12 chr19:45420343 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
4.68e-12 chr19:45336599 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
4.79e-12 chr19:45486687 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
5.01e-12 chr19:45421877 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
N/A
5.37e-12 chr19:45383830 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45426105
5.50e-12 chr19:45426105 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
5.89e-12 chr19:45418961 NG00041
Neuropathologic features of AD and related dementias (case/control)
GWAS summary statistics from a comparative study of neuropathological features of Alzheimer's disease and related dementias: general case/control analysis comparing individuals with dementia and AD neuropathologies (cases) to those without clinical dementia and none or minimal AD neuropathologic changes (controls); includes both primary (relaxed documentation) and conservative (strict documentation) datasets
chr19:45408836
6.17e-12 chr19:45408836 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
6.76e-12 chr19:45485491 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45428083
6.76e-12 chr19:45428083 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
chr19:45427353
7.24e-12 chr19:45427353 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
8.13e-12 chr19:45338895 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
8.71e-12 chr19:45351746 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
N/A
9.33e-12 chr19:45342630 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45426637
9.55e-12 chr19:45426637 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
1.00e-11 chr19:45383037 NG00027
ADGC 2011: Stage 2
summary statistics for ADGC (2011): stage 2, unadjusted
N/A
1.00e-11 chr19:45351937 NG00027
ADGC 2011: Stage 1
summary statistics for ADGC (2011): stage 1, unadjusted
chr19:45408564
1.15e-11 chr19:45408564 NG00048
ADGC Age of Onset LOAD
GWAS summary statistics for age of onset in ADGC LOAD GWAS datasets, after adjustment for sex, APOE ε4 number, and population stratification.
N/A
1.29e-11 chr19:45450033 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.32e-11 chr19:45450408 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
chr19:45405521
1.35e-11 chr19:45405521 NG00039
ADGC African Americans (2013)
GWAS summary statistics from an ADGC study of African Americans and their genetic risk for LOAD (2013)
N/A
1.41e-11 chr19:45454759 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.48e-11 chr19:45455706 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.48e-11 chr19:45340728 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.51e-11 chr19:45422946 NG00027
ADGC 2011: Stage 1 Adjusted for Age, Sex and APOE
summary statistics for ADGC (2011): stage 1, adjusted for APOE, Age, and Sex
N/A
1.55e-11 chr19:45381292 NG00036
IGAP 2013: Stage 1
summary statistics for IGAP (2013): stage 1
N/A
1.58e-11 chr19:45485626 NG00036
IGAP 2013: Stage 1